Skip to content

Autonomic Differences in Heart Rate Variability Between Healthy and Chronic Low Back Pain Subjects

CompletedNCT06760390
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This study aims to evaluate the autonomic differences in heart rate variability (HRV) between healthy individuals and those with chronic low back pain. By analyzing HRV parameters, such as time-domain, frequency-domain, and non-linear metrics, this cross-sectional study seeks to explore the impact of chronic pain on the autonomic nervous system. The study will provide insights into parasympathetic and sympathetic modulation and its potential relationship with chronic pain symptoms. Participants include healthy adults and individuals with chronic low back pain aged 18-65.

Study details

Official title
Cross-Sectional Analysis of Autonomic Differences in Heart Rate Variability Between Healthy Individuals and Subjects with Chronic Low Back Pain
Conditions
Sponsor
Universidad de Extremadura
Start date
2020-11-01
Primary completion
2020-11-30
Sex
All
Age range
from 18 Years to 65 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Countries
Spain
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults aged between 18 and 65 years. For the chronic low back pain group: * Diagnosis of chronic low back pain lasting at least three months. * A minimum pain intensity of 3/10 on the Numerical Pain Rating Scale (NPRS). For the healthy group: * Absence of any chronic or acute pathology. * No regular medication that could alter autonomic nervous system function. * No episodes of low back pain in the past six months. Exclusion Criteria: * Presence of uncontrolled neurological or cardiac disorders. * Use of medications that could influence autonomic function or pain perception (e.g., opioids, antidepressants, benzodiazepines, anti-inflammatory drugs, beta-blockers) within two weeks prior to the study. * Body Mass Index (BMI) equal to or greater than 30 kg/m².

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06760390